Cubist Systematic Strategies, LLC Novartis Ag Call Options Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $3.02 Million - $3.42 Million	-32,600 Reduced 90.56%	3,400 $343,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $4.2 Million - $4.87 Million	-52,500 Reduced 59.32%	36,000 $3.31 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $1.5 Million - $1.84 Million	-19,900 Reduced 18.36%	88,500 $8.03 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $7.36 Million - $8.61 Million	98,700 Added 1017.53%	108,400 $8.24 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $781,044 - $909,375	9,700 New	9,700 $820,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.